Article · Volume 6, Issue 1 · pp. 158–160

Recurrence of atrial fibrillation after switching from brand to generic atenolol

Luca Gallelli¹, Francesca Maida¹, Orietta Staltari¹, Pierandrea Rende¹, Emilio Russo¹, Benedetto Caroleo¹

¹Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.

Abstract

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Keywords: Atenolol; atrial fibrillation; brand drug; clinical ineffectiveness; generic drug

The full text of this article is available as a PDF. Open the PDF.